Literature DB >> 11380818

Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?

J P Cosyns1, J P Dehoux, Y Guiot, R M Goebbels, A Robert, A M Bernard, C van Ypersele de Strihou.   

Abstract

BACKGROUND: Chinese herbs nephropathy (CHN) is a new type of subacute interstitial nephritis that is attributed to aristolochic acid (AA), which inadvertently has been included in slimming pills. The contribution of other simultaneously prescribed drugs remains disputed. In the present study, the effects of a chronic intake of AA given as a single drug was evaluated through renal histology and function in rabbits.
METHODS: Female New Zealand White rabbits were injected intraperitoneally with either 0.1 mg AA/kg or with saline 5 days a week for 17 to 21 months. Body weight, renal function, and urinary excretion of glucose and low molecular weight proteins were monitored prior to sacrifice at the end of the study period.
RESULTS: All animals given AA developed renal hypocellular interstitial fibrosis, which was classified into three patterns. Fibrosis was confined to medullary rays (MRs) in pattern I (N = 3), extended to the outer cortical labyrinth (OCL) in pattern II (N = 2), and eventually to the inner cortical labyrinth (ICL) in pattern III (N = 6). Fibrosis in MR and OCL was associated with mainly proximal tubular epithelial cell flattening. All treated animals displayed urothelial atypia. Three of them also developed tumors of the urinary tract. No significant pathologic changes were found in control rabbits. AA-treated animals differed from controls by an impaired growth, increased serum creatinine, glucosuria, tubular proteinuria, and anemia.
CONCLUSION: The observed pattern of renal histopathological lesions and disorders of the renal function, as well as urothelial atypia and malignancy, are very reminiscent of CHN. Our observations therefore support a causal role of AA alone in the genesis of this new nephropathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11380818     DOI: 10.1046/j.1523-1755.2001.00731.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  34 in total

1.  Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.

Authors:  Bojan Jelaković; Xavier Castells; Karla Tomić; Maude Ardin; Sandra Karanović; Jiri Zavadil
Journal:  Int J Cancer       Date:  2014-12-10       Impact factor: 7.396

2.  [Evaluation of renal oxygenation in rats with acute aristolochic acid nephropathy using blood oxygenation level-dependent magnetic resonance imaging].

Authors:  Guixiang Yang; Yingjie Mei; Jian Lü; Quan Tao; Yanqiu Feng; Yikai Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

3.  The transcription factor Twist1 in the distal nephron but not in macrophages propagates aristolochic acid nephropathy.

Authors:  Jiafa Ren; Nathan P Rudemiller; Yi Wen; Xiaohan Lu; Jamie R Privratsky; Steven D Crowley
Journal:  Kidney Int       Date:  2019-08-13       Impact factor: 10.612

4.  Shorter hemodialysis duration is a risk factor for the recurrence of urothelial carcinoma of the bladder in patients on maintenance hemodialysis.

Authors:  S-L Liu; L Qi; W-Q Han; B-S Zhu; X Zhou; S-S Jiang; M-F Chen; Y Li; W He; L-F Liu; X-H Hu; Y Xie; F-H Zeng; X-B Zu
Journal:  Clin Transl Oncol       Date:  2015-07-29       Impact factor: 3.405

5.  Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells.

Authors:  Keiji Hashimoto; Irina N Zaitseva; Radha Bonala; Sivaprasad Attaluri; Katherine Ozga; Charles R Iden; Francis Johnson; Masaaki Moriya; Arthur P Grollman; Viktoriya S Sidorenko
Journal:  Carcinogenesis       Date:  2016-04-18       Impact factor: 4.944

Review 6.  Non-drug-induced nephrotoxicity.

Authors:  Justine Bacchetta; Laurence Dubourg; Laurent Juillard; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2009-04-28       Impact factor: 3.714

Review 7.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.

Authors:  Li Zhou; Ping Fu; Xiao R Huang; Fei Liu; Kar Neng Lai; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

9.  beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism.

Authors:  Ying Xiao; Xiang Xue; Yuan-feng Wu; Guo-zheng Xin; Yong Qian; Tian-pei Xie; Li-kun Gong; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

10.  DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells.

Authors:  Sivaprasad Attaluri; Radha R Bonala; In-Young Yang; Mark A Lukin; Yujing Wen; Arthur P Grollman; Masaaki Moriya; Charles R Iden; Francis Johnson
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.